SIRPA and myocardial infarction: In this study, we introduced a biomimetic liposome as a nano‐degrader to degrade SIRPα on macrophage membrane and tested the effect on inhibition of CD47‐SIRPα immune checkpoint in myocardial infarction as the disease model.